drugset / Trial / NCT03826563

Melatonin Effects on Sleep and Circadian Rhythm in Youth and Young Adults With At-risk Symptoms

NCT03826563

RandomizedParallel-groupQuadruple-blindOther

Summary

Randomized control trial assessing supplemental melatonin for youth with at-risk or psychotic symptoms.

Timeline

Start
2019-01-18
Primary completion
2023-04-07
Completion
2023-04-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 2.5 mg Oral
Subject Melatonin Small molecule 5 mg Oral
Subject Melatonin Small molecule 10 mg Oral

Indications